The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Global Fabry Disease Market - 2024-2033
US$ 2,999.00
The Global Fabry Disease Market was valued at US$ 2.13 Billion in 2024 and is anticipated to reach US$ 4.03 Billion by 2033, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-depth insights...
June 2025
223 pages
Spinal Muscular Atrophy Market - 2024-2033
US$ 2,999.00
The Spinal Muscular Atrophy Market was valued at US$ 4.40 Billion in 2024 and is anticipated to reach US$ 20.06 Billion by 2033, at a CAGR of 0.165 from 2026 to 2032. The report delivers in-depth insi...
June 2025
218 pages
Global Achondroplasia Market - 2023-2033
US$ 2,999.00
The Global Achondroplasia Market was valued at US$ 144.55 Million in 2023 and is anticipated to reach US$ 366.85 Million by 2033, at a CAGR of 0.099 from 2026 to 2032. The report delivers in-depth ins...
June 2025
218 pages
Global Phenylketonuria Treatment Market - 2023-2033
US$ 2,999.00
The Global Phenylketonuria Treatment Market was valued at US$ 538.84 Million in 2023 and is anticipated to reach US$ 1,140.37 Million by 2033, at a CAGR of 0.084 from 2026 to 2032. The report delivers...
June 2025
207 pages
Global Hereditary Angioedema (HAE) Market - 2024-2033
US$ 2,999.00
The Global Hereditary Angioedema (HAE) Market was valued at US$ 3.31 Billion in 2024 and is anticipated to reach US$ 6.40 Billion by 2033, at a CAGR of 0.077 from 2026 to 2032. The report delivers in-...
June 2025
220 pages
Global Rett Syndrome Market - 2024-2033
US$ 2,999.00
The Global Rett Syndrome Market was valued at US$ 409.88 Million in 2024 and is anticipated to reach US$ 972.11 Million by 2033, at a CAGR of 0.101 from 2026 to 2032. The report delivers in-depth insi...
June 2025
210 pages
Antibacterial Drugs Market - 2024-2033
US$ 2,999.00
The Antibacterial Drugs Market was valued at US$ 61.02 Billion in 2024 and is anticipated to reach US$ 81.75 Billion by 2033, at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insight...
June 2025
200 pages
Global Spinocerebellar Ataxia Market - 2023-2033
US$ 2,999.00
The Global Spinocerebellar Ataxia Market was valued at US$ 347.52 Million in 2023 and is anticipated to reach US$ 706.72 Million by 2033, at a CAGR of 0.074 from 2026 to 2032. The report delivers in-d...
June 2025
217 pages
Chronic Lower Back Pain Drugs Market - 2024-2033
US$ 2,999.00
The Chronic Lower Back Pain Drugs Market was valued at US$ 2,768.82 million in 2024 and is anticipated to reach US$ 4,608.47 million by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers...
June 2025
218 pages
Global Enzyme Replacement Therapy Market - 2024-2032
US$ 2,999.00
The Global Enzyme Replacement Therapy Market was valued at US$ 11.05 billion in 2024 and is anticipated to reach US$ 21.67 billion by 2032, at a CAGR of 0.087 from 2026 to 2032. The report delivers in...
June 2025
243 pages
Global Short Bowel Syndrome Market - 2024-2033
US$ 2,999.00
The Global Short Bowel Syndrome Market was valued at US$ 1.64 Billion in 2024 and is anticipated to reach US$ 7.93 Billion by 2033, at a CAGR of 0.193 from 2026 to 2032. The report delivers in-depth i...
June 2025
220 pages
Anticholinergic Drugs Market 2026
US$ 2,999.00
The Anticholinergic Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.044 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
June 2025
210 pages
Hemophilia Market - 2024-2033
US$ 2,999.00
The Hemophilia Market was valued at US$ 13.03 Billion in 2024 and is anticipated to reach US$ 21.82 Billion by 2033, at a CAGR of 0.059 from 2026 to 2032. The report delivers in-depth insights into ke...
June 2025
210 pages
Parathyroid Hormone Market 2026
US$ 2,999.00
The Parathyroid Hormone Market was valued at in and is anticipated to reach by , at a CAGR of 0.034 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
June 2025
243 pages
Antimetabolite Drugs Market - 2024-2033
US$ 2,999.00
The Antimetabolite Drugs Market was valued at US$ 9.38 Billion in 2024 and is anticipated to reach US$ 12.53 Billion by 2033, at a CAGR of 0.033 from 2026 to 2032. The report delivers in-depth insight...
May 2025
207 pages
Arthralgia Treatment Market 2026
US$ 2,999.00
The Arthralgia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
May 2025
200 pages
Lupus Nephritis Treatment Market 2026
US$ 2,999.00
The Lupus Nephritis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
May 2025
217 pages
Metabolism Drugs Market - 2024-2033
US$ 2,999.00
The Metabolism Drugs Market was valued at US$ 8,475.56 Million in 2024 and is anticipated to reach US$ 14,336.48 Million by 2033, at a CAGR of 0.064 from 2026 to 2032. The report delivers in-depth ins...
May 2025
243 pages
CLOVES Syndrome Market 2026
US$ 2,999.00
The CLOVES Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional grow...
May 2025
219 pages
Cutaneous Lupus Erythematosus Market 2026
US$ 2,999.00
The Cutaneous Lupus Erythematosus Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
May 2025
223 pages
Hereditary Hemochromatosis Market 2026
US$ 2,999.00
The Hereditary Hemochromatosis Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
May 2025
207 pages
Hyperparathyroidism Treatment Market 2026
US$ 2,999.00
The Hyperparathyroidism Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
May 2025
220 pages
Pyelonephritis Treatment Market - 2024-2033
US$ 2,999.00
The Pyelonephritis Treatment Market was valued at US$ 1,014.39 million in 2024 and is anticipated to reach US$ 1,682.83 billion by 2033, at a CAGR of 0.058 from 2026 to 2032. The report delivers in-de...
May 2025
243 pages
